{"version":"1.0","type":"link","title":"Case Report: Dual checkpoint inhibition with bevacizumab yields dramatic response in synchronous double primary HCC and ICC with lung metastasis.","author_name":"He YC 외","author_url":"https://prs-insight.online/author/He%20YC","provider_name":"PRSinsight","provider_url":"https://prs-insight.online","thumbnail_url":"https://prs-insight.online/og/paper/117155","thumbnail_width":1200,"thumbnail_height":630}